Inward Investor: Teva is ready to reap a generic windfall
Teva Pharmaceutical Industries, which has a significant presence in Ireland, is well positioned to benefit from the increased demand for generic drugs.
The multibillion dollar generic drug industry is both a cut-throat and highly lucrative one in which small 'David' drug makers are snapped up by Goliath pharma companies constantly on the look-out for the next big thing in order to ensure their survival.
The expiry of patent protection on several heavyweight drugs over the next three years is expected to herald a golden era of productivity and prosperity for generic drug manufacturers.
The pharmaceutical companies most...
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month, €19.99 Monthly thereafter
*New subscribers only
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Unlimited Access for 2 Years
Get a Business Account for you and your team